Živko Mukaetov
Živko Mukaetov is the General Director and Chairman of the Board of 'Alkaloid', a leading pharmaceutical company based in North Macedonia. Under his leadership, the company has focused on innovation and has achieved significant milestones in drug development, including the creation of a patented liquid form of Omeprazole. This innovation aims to improve treatment options for pediatric patients suffering from gastroesophageal reflux disease (GERD), showcasing Alkaloid's commitment to enhancing healthcare and quality of life for families dealing with this common condition. Mukaetov's work emphasizes the importance of accessibility and effectiveness in medical treatments.
Global Media Ratings
Countries Mentioned
| Country | Mentions | Sentiment | Dominance | + Persistence | x Population | = Reach | x GDP (millions) | = Power |
|---|---|---|---|---|---|---|---|---|
| North Macedonia | 1 | 7.00 | 0.13% | +0% | 2,083,374 | 2,614 | $12,800 | 16$ |
| Totals | 1 | 2,083,374 | 2,614 | $12,800 | 16$ |
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
North Macedonia:
Zivko Mukaetov expressed hope that the European Handball Federation will make the right decision regarding the unplayed match.
7
North Macedonia:
Zivko Mukaetov highlights the visionary unity of the members of 'Macedonia 2025' as crucial for its longevity.
9
North Macedonia:
Živko Mukaetov is the General Director and President of the Management Board of 'Alkaloid'.
9